Cervical Cancer

 
How to Address Patient Hesitancy Around Cervical Cancer Screening with Ada Stewart, MD
September 10, 2025

Ada Stewart, MD, shares strategies for primary care physicians to reduce patient anxiety and improve comfort during cervical cancer screening exams.

Cervical Cancer Screening Guidelines: Key Updates for Primary Care Physicians
September 09, 2025

Expert discusses when to start screening, available test options, and recommended intervals for women aged 21 to 65 years.

US Counties With Low Screening See Higher Cervical Cancer Death Rates: Daily Dose
September 04, 2025

Your daily dose of the clinical news you may have missed.

Persistent Low Cervical Cancer Screening Tied to Nearly Double Incidence and Mortality in US Counties
August 13, 2025

Rural, low-income US counties with persistently low cervical cancer screening have almost twice the incidence and mortality compared with high-screening counties.

Unnecessary Cancer Screenings in the US Persist Long After Guidelines Shift: Daily Dose
July 09, 2025

Your daily dose of the clinical news you may have missed.

New Study Highlights Lengthy Journey to Phase Out Low-Value Cancer Screenings in the US
June 12, 2025

Valid and accessible measures are needed to monitor low-value care practices and set benchmarks for de-implementation efforts, researchers reported.

FDA Clears First At-Home Pap Smear Alternative for Cervical Cancer Screening: Daily Dose
May 27, 2025

Your daily dose of the clinical news you may have missed.

Smoking Rates Hit New Low, But Cervical Cancer Screening Still Lags: 2025 ACS Report
April 24, 2025

While smoking in the US continues to decline, the American Cancer Society reports mixed progress in major cancer risk factors, prevention, and screening.

Uneven US Cancer Screening Recovery Post-COVID: Daily Dose
April 01, 2025

Your daily dose of the clinical news you may have missed.

Study: COVID-19 Pandemic Disruptions in Cancer Screening Show Uneven Recovery in 2023
March 12, 2025

Cervical cancer screening rates remained below prepandemic levels, while rates for breast and colorectal cancers rebounded from pandemic declines.